Answers are grounded in this paper and cite their sources.
The lenticulostriate arteries (LSAs) are crucial cerebral microvasculature vessels, supplying blood to the basal ganglia and internal capsule. Diagnosing, recognizing, and treating cognitive impairment in cerebral small vessel disease (CSVD) is challenging due to complex pathogenesis and unstudied mechanisms. This section reviews LSAs-related CSVD literature, analyzes microvascular injury mechanisms, explores pathophysiological events in T2DM patients, including blood flow disorders, neurovascular unit dysfunction, and blood-brain barrier disruption, and their relationship to cognitive impairment. We investigate LSAs structure and vascular changes to identify biomarkers for cognitive impairment. We explain CSVD's role in cognitive symptoms and brain network disconnections, and study vascular risk factors' impact on LSAs and cognitive decline, considering LSAs as potential therapeutic targets. • Investigates the cellular and molecular mechanisms underlying lenticulostriate arteries (LSAs) injury-induced cerebral small vessel diseases, providing novel insights into vascular cognitive impairment pathogenesis. • Elucidates the triad of pathophysiological events - cerebral hemodynamic dysregulation, neurovascular unit destabilization, and blood-brain barrier compromise - in T2DM patients with LSAs abnormalities, establishing their synergistic contribution to cognitive decline. • Reveals LSAs structural-functional alterations as critical drivers of cognitive dysfunction progression, proposing neuroimaging biomarkers for early detection and longitudinal monitoring of vascular cognitive impairment.
No takes yet. Share an insight, caveat, or question.
Wu et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: